A detailed history of Capital Advisory Group Advisory Services, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Advisory Group Advisory Services, LLC holds 4,089 shares of ABT stock, worth $479,476. This represents 0.19% of its overall portfolio holdings.

Number of Shares
4,089
Previous 4,089 -0.0%
Holding current value
$479,476
Previous $424,000 9.91%
% of portfolio
0.19%
Previous 0.18%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $4,029 - $4,497
-40 Reduced 0.97%
4,089 $424,000
Q1 2024

Apr 18, 2024

SELL
$109.52 - $120.96 $12,704 - $14,031
-116 Reduced 2.73%
4,129 $469,000
Q3 2023

Oct 18, 2023

BUY
$95.53 - $114.62 $405,524 - $486,561
4,245 New
4,245 $411,000
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $13,172 - $15,505
136 Added 3.42%
4,113 $416,000
Q3 2022

Nov 07, 2022

BUY
$96.76 - $112.03 $23,415 - $27,111
242 Added 6.48%
3,977 $385,000
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $8,267 - $9,992
-81 Reduced 2.12%
3,735 $399,000
Q1 2022

Apr 29, 2022

SELL
$114.02 - $139.04 $8,779 - $10,706
-77 Reduced 1.98%
3,816 $452,000
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $22,297 - $27,301
-193 Reduced 4.72%
3,893 $548,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $7,116 - $7,872
61 Added 1.52%
4,086 $483,000
Q2 2021

Nov 12, 2021

SELL
$105.79 - $124.53 $12,694 - $14,943
-120 Reduced 2.9%
4,025 $467,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $21,114 - $24,876
-194 Reduced 4.47%
4,145 $497,000
Q4 2020

Feb 18, 2021

BUY
$105.0 - $114.42 $26,985 - $29,405
257 Added 6.3%
4,339 $475,000
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $3,024 - $3,672
-33 Reduced 0.8%
4,082 $444,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $108,040 - $138,278
1,411 Added 52.18%
4,115 $376,000
Q1 2020

May 18, 2020

SELL
$62.82 - $91.86 $54,339 - $79,458
-865 Reduced 24.24%
2,704 $213,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $78 - $87
1 Added 0.03%
3,569 $309,000
Q3 2019

May 28, 2020

BUY
$81.84 - $88.74 $163 - $177
2 Added 0.06%
3,568 $297,000
Q2 2019

May 28, 2020

BUY
$72.88 - $85.0 $72 - $85
1 Added 0.03%
3,566 $299,000
Q1 2019

May 28, 2020

BUY
$66.22 - $80.06 $132 - $160
2 Added 0.06%
3,565 $286,000
Q4 2018

May 28, 2020

BUY
$65.56 - $74.27 $131 - $148
2 Added 0.06%
3,563 $257,000
Q3 2018

May 28, 2020

BUY
$60.81 - $73.36 $121 - $146
2 Added 0.06%
3,561 $262,000
Q2 2018

May 28, 2020

BUY
$57.57 - $63.54 $172 - $190
3 Added 0.08%
3,559 $217,000
Q1 2018

May 28, 2020

BUY
$56.27 - $63.62 $200,096 - $226,232
3,556 New
3,556 $214,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.